|Bid||1.01 x 800|
|Ask||0.00 x 800|
|Day's Range||226.94 - 232.11|
|52 Week Range||215.24 - 260.26|
|PE Ratio (TTM)||64.34|
|Earnings Date||Jun 7, 2018|
|Forward Dividend & Yield||0.06 (0.03%)|
|1y Target Est||270.54|
Holly Sheffield has been appointed Executive Vice President and Chief Strategy Officer of The Cooper Companies, effective June 4, 2018. In this position, Holly will be responsible for corporate strategy, business development and global human resources with a strong focus on driving long-term shareholder value. Holly will report directly to Albert White, President and CEO.
PLEASANTON, Calif., May 21, 2018-- The Cooper Companies, Inc. will present at the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, CA, on June 14, 2018. Daniel G. McBride, Esq, Executive Vice ...
ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference.
PLEASANTON, Calif., May 17, 2018-- The Cooper Companies, Inc. will present at the William Blair Growth Stock Conference in Chicago, Illinois, on June 13, 2018. Albert G. White III, President and Chief ...
Medtronic (MDT) focuses on boosting CSH segment. Notably, successful results from The Bifurcation Cohort study will help the company to achieve expanded FDA approval for the Resolute Onyx DES.
Cardinal Health (CAH) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.
The Cooper Companies Inc (NYSE:COO) trades with a trailing P/E of 64.8x, which is higher than the industry average of 38.8x. While this makes COO appear like a stock toRead More...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support.
PLEASANTON, Calif., April 23, 2018-- The Cooper Companies, Inc. today announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The Cooper Companies ...
LONDON, UK / ACCESSWIRE / April 18, 2018 / Active-Investors.com has just released a free earnings report on The Cooper Cos., Inc. (NYSE: COO). Cooper Cos. reported its first quarter fiscal 2018 operating and financial results on March 08, 2018. The medical device Company surpassed top- and bottom-line expectations.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding COO totaled $16.70 billion.
Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PLEASANTON, Calif., April 03, 2018-- The Cooper Companies, Inc. today announced that CooperSurgical has acquired the assets of The LifeGlobal Group and its affiliates, a leading global provider of in-vitro ...
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.